Moreover, LBH was upregulated in liver hepatocellular carcinoma (LIHC; +1.5 to 2.5-fold), stomach adenocarcinoma (STAD; +1.8 to 2.0-fold), and in the aggressive brain cancer, glioblastoma (GBM; +1.7 to 3.3-fold) (Fig. 1D.xi–xiii; Fig. S1A.xi–xiii), congruous with previous reports [15–19]. This evidence concerns the gene LBH and brain cancer.